Skip to content
healthcare.dev
Get a free key

Deferasirox oral

NDC 67877-676, Deferasirox oral, granule, from Ascend Laboratories, LLC.

Product NDC
67877-676
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213374
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-676 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX180 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
67877-676-846787706768430 PACKET in 1 CARTON (67877-676-84) / 1 GRANULE in 1 PACKET (67877-676-72)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2c2842a0-7781-4047-84cd-88bd018e10c7

Use it

Look up 67877-676 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-676 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-676. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.